Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-01Clinical Trial Results: Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99) [Phase 2]
Phase 2 trial evaluating pembrolizumab combined with chemotherapy and investigational agents as first-line treatment for extensive-stage sma…
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 [Phase 1]
Phase 1 trial of GD2-SADA:177Lu-DOTA complex for GD2-expressing solid tumors was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Update: Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) [Phase 3]
Phase 3 trial evaluating tarlatamab after chemoradiotherapy in limited-stage small cell lung cancer is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial evaluating BL0020 in combination with toripalimab for recurrent extensive-stage small cell lung cancer; the study s…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors [Phase 1, Phase 2]
A Phase I/II clinical trial is evaluating the combination of sacituzumab govitecan and berzosertib in small cell lung cancer, extrapulmonary…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax [Phase 2]
Phase 2 trial evaluating durvalumab as maintenance therapy after thoracic chemoradiotherapy in frail patients with thorax-limited small cell…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Tarlatamab for SCLC Brain Metastases [Phase 2]
Maastricht University Medical Center is conducting a Phase 2 trial of tarlatamab for adults with small cell lung cancer and brain metastases…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC) [Phase 1]
A Phase 1 study evaluating Tarlatamab in combination with YL201, with or without anti-PD-L1, in extensive-stage small cell lung cancer is ac…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas [Phase 2]
Phase 2 clinical trial update evaluating niraparib and dostarlimab for small cell lung cancer and other high-grade neuroendocrine carcinomas…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2 [Phase 2]
Phase 2 study evaluating Tarlatamab in pretreated extensive-stage small cell lung cancer with ECOG performance status 2 is currently recruit…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung Cancer
Daiichi Sankyo offers a medical access program for Ifinatamab Deruxtecan in third-line or later extensive-stage small cell lung cancer, with…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002) [Phase 1, Phase 2]
This clinical trial update reports the ongoing Phase 1/2 study evaluating Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in relapsed/…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Benmelstobart in combination with Anlotinib, chemotherapy, and thoracic radiation for limited-stage small cell lung…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy [Phase 2]
Phase 2 trial update reporting safety and early effectiveness signals for BNT327 in combination with chemotherapy for small-cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies [Phase 1]
Phase 1 trial evaluating CTX-471 as a monotherapy or in combination with pembrolizumab in patients who progressed after PD-1/PD-L1 inhibitor…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer(PANKU-Lung03) [Phase 3]
Phase 3 trial comparing BL-B01D1 to Topotecan in recurrent small cell lung cancer is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: The Effect of Pulmonary Rehabilitation on Pulmonary Function Tests, Exercise Capacity, and Quality of Life in Patients With Advanced-Stage Lung Cancer Receiving Chemotherapy [NA]
The document reports the completion of a clinical trial evaluating whether pulmonary rehabilitation improves lung function tests, exercise c…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC) [Phase 1]
Phase 1 study evaluating tarlatamab and ZL-1310, with or without anti-PD-L1, in small cell lung cancer; the trial is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer [Phase 1]
Phase 1 trial assessing the tolerability of BI 764532 at multiple dose levels when added to standard of care in adults with advanced small c…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer [Phase 2]
Phase 2 trial of Monalizumab in combination with durvalumab for small cell lung cancer is currently suspended.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy [Phase 1]
Phase 1 study update (DAREON-9) evaluating tolerability of varying doses of BI 764532 in combination with a single-agent chemotherapy in sma…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: MDT-Based Nursing for Small Cell Lung Cancer During Chemo-Immunotherapy [NA]
This completed clinical trial evaluated multidisciplinary-team-based nursing for patients with small cell lung cancer during chemo-immunothe…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy [Phase 1]
Phase 1 trial update evaluating Debio 0123 in combination with carboplatin and etoposide in adults with small cell lung cancer that recurred…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Study of Trilaciclib and Lurbinectidin [Phase 2]
A Phase 2 clinical trial evaluating the combination of trilaciclib and lurbinectedin for lung cancer, including small cell lung cancer, is c…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating Nanrilkefusp alfa alone and with pembrolizumab in adults with advanced or metastatic solid tumors; the study (NCT04…